NCT04044638 is a NA clinical trial of Resistance trainining in Blood Pressure, sponsored by Universidade Regional do Cariri.

Who is sponsoring NCT04044638?

NCT04044638 is sponsored by Universidade Regional do Cariri.

What drugs are being tested in NCT04044638?

Interventions in NCT04044638: Resistance trainining.

What condition does NCT04044638 study?

NCT04044638 studies Blood Pressure, Resistance Training, Women.

Is NCT04044638 still recruiting?

NCT04044638 is currently completed. Last updated 5 August 2019.

Last reviewed 2019-08-05 · How we verify

NCT04044638

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Eight Week Strength Training Reduces Blood Pressure of Middle Age Women

Completed NA Last updated 5 August 2019

What this trial tests

NA trial testing Resistance trainining in Blood Pressure in 14 participants. Completed in 30 April 2018.

Timeline

5 March 2018

Primary endpoint
2 April 2018

30 April 2018

Quick facts

Lead sponsor	Universidade Regional do Cariri
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	14
Start date	5 March 2018
Primary completion	2 April 2018
Estimated completion	30 April 2018
Sites	1 location across Brazil

Drugs / interventions tested

Resistance trainining

Conditions studied

Blood Pressure — all drugs for Blood Pressure →
Resistance Training — all drugs for Resistance Training →
Women — all drugs for Women →

Sponsor

Universidade Regional do Cariri

Who can join

Adults 18 to 59, female only, with Blood Pressure or Resistance Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Strength training (ST) is an important non-pharmacological means to reduce blood pressure (BP). Objective: To verify the pressure response of women after 8 weeks of ST. Method: Fourteen women were divided into young group (YG) and middle age (MAG) and submitted to ST for 8 weeks, lasting 60 minutes in 11 alternating exercises per segment with intensity of 12 to 13 on the subjective perception scale of effort. BP was verified at weeks 1, 4 and 8.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04044638 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Regional do Cariri
Last refreshed: 5 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04044638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing